Announcement
16 Mar 2021
The Canadian government provides funding to Novocol Pharma to support the expansion of Novocol’s fill-finish services.
Source
Sign in to access
Number of interventions
1
1 certainly harmful
0 likely harmful
0 liberalising
List of interventions
Implementation date
16 Mar 2021
Revocation date:
No revocation date
Updated: 16 Mar 2021
State loan
In force
On 16 March 2021, Novocol Pharmaceutical of Canada announced securing CAD 32.7 million (USD 26.2 million) from the government to expand its biomanufacturing facilities in Cambridge, Ontario. The co...
Sign in to see more
Related State Acts
18 May 2021
Canada: Government announces funding for a Canadian biomanufacturing company
16 Mar 2021
Canada: KABS Laboratories secure CAD 52.2 million from the Strategic Innovation Fund
16 Mar 2021
Canada: Government provides funding to a Canadian biotechnology company through Phase II clinical trials of a therapeutic candidate against COVID-19
23 Mar 2020
Canada: Government allocates CAD 792 million for the development and production of medical countermeasures to COVID-19
Threads
See all
This state act is not part of any Thread yet.